Search - tctmd.com

Displaying 61 - 80 of 1020

Sort: Relevancy | Date

Presentation TVT 2022

Cardiovalve TMVR System; a Novel Treatment Option for Patients with Mitral Regurgitation (1 Recorded Case)

Presenter: Karl-Heinz Kuck

June 10, 2022

Presentation TVT 2022

What's best for my patient when it comes to their post-implant drug regimen?

Presenter: Megan Coylewright

June 10, 2022

Presentation TVT 2022

Cardiovalve TMVR System; a Novel Technology for Patients with Mitral Regurgitation

Presenter: Francesco Maisano

June 10, 2022

Presentation TVT 2022

TEER vs. TMVR for FMR - Time for RCT?

Presenter: Gorav Ailawadi

June 10, 2022

Presentation TVT 2022

Beyond the IDEs: Lessons from today's real-world data

Presenter: Matthew Price

June 10, 2022

Presentation TVT 2022

Current Landscape of TMVR technologies - a Frank Appraisal

Presenter: Azeem Latib

June 10, 2022

Presentation TVT 2022

M3

Presenter: David Daniels

June 10, 2022

Presentation TVT 2022

APOLLO

Presenter: Martin B. Leon

June 10, 2022

Presentation TVT 2022

SUMMIT

Presenter: Gorav Ailawadi

June 10, 2022

Presentation TVT 2022

TAVR Unload

Presenter: Nicolas Van Mieghem

June 10, 2022

Presentation TVT 2022

Exercise PVR, A Key Predictor of Benefit of Atrial Shunt Therapy in HFpEF?

Presenter: Sanjiv Shah

June 10, 2022

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

Presentation TVT 2022

Residual ASD Post-TMVR: Severity Assessment and Indication for Closure

Presenter: Torsten P. Vahl

June 10, 2022

Presentation TVT 2022

LVOT Obstruction Post-TMVR: Predictors, Prevention, and Post-interventional Management

Presenter: Vinayak N. Bapat

June 10, 2022

RELIEVE HF: Different Patient Selection and Study Design – Should We Expect Different Results?

Presentation TVT 2022

Less Invasive Ventricular Enhancement for HFrEF

Presenter: John Boehmer

June 10, 2022

Presentation TVT 2022

Post-TAVR Heart Failure: Mechanism, Incidence, Risk Factors, and Treatment

Presenter: Chetan Huded

June 10, 2022

Presentation TVT 2022

What (Else) Have We Learned From REDUCE-LAP II?

Presenter: Sanjiv Shah

June 10, 2022

Presentation TVT 2022

Patient Selection in TMVR Trials: Where Surgery and Catheter-based Therapies Separate or Overlap

Presenter: Eberhard Grube

June 10, 2022

Presentation TVT 2022

Overview of the Interatrial Shunt Device Landscape: Conceptual Basis and Devices

Presenter: Daniel Burkhoff

June 10, 2022

Presentation TVT 2022

When a Watchman Goes Wayward!

Presenter: Arka Chatterjee

June 10, 2022

Advertisement

Cardiovalve TMVR System; a Novel Treatment Option for Patients with Mitral Regurgitation (1 Recorded Case)

What's best for my patient when it comes to their post-implant drug regimen?

Cardiovalve TMVR System; a Novel Technology for Patients with Mitral Regurgitation

TEER vs. TMVR for FMR - Time for RCT?

Beyond the IDEs: Lessons from today's real-world data

Current Landscape of TMVR technologies - a Frank Appraisal

M3

APOLLO

SUMMIT

TAVR Unload

Exercise PVR, A Key Predictor of Benefit of Atrial Shunt Therapy in HFpEF?

More Support for Single Antiplatelet Therapy After TAVI

Residual ASD Post-TMVR: Severity Assessment and Indication for Closure

LVOT Obstruction Post-TMVR: Predictors, Prevention, and Post-interventional Management

Less Invasive Ventricular Enhancement for HFrEF

Post-TAVR Heart Failure: Mechanism, Incidence, Risk Factors, and Treatment

What (Else) Have We Learned From REDUCE-LAP II?

Patient Selection in TMVR Trials: Where Surgery and Catheter-based Therapies Separate or Overlap

Overview of the Interatrial Shunt Device Landscape: Conceptual Basis and Devices

When a Watchman Goes Wayward!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content